rs6012006
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001011554.3(SLC13A3):c.-127-6247T>G variant causes a intron change. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001011554.3 intron
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarateInheritance: AR, Unknown Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001011554.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.724 AC: 103707AN: 143210Hom.: 38407 Cov.: 20 show subpopulations
GnomAD4 genome AF: 0.724 AC: 103799AN: 143294Hom.: 38452 Cov.: 20 AF XY: 0.719 AC XY: 49808AN XY: 69232 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.